These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31729155)

  • 41. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.
    Dashkevich A; Raissadati A; Syrjälä SO; Zarkada G; Keränen MA; Tuuminen R; Krebs R; Anisimov A; Jeltsch M; Leppänen VM; Alitalo K; Nykänen AI; Lemström KB
    Am J Transplant; 2016 Apr; 16(4):1160-72. PubMed ID: 26689983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tertiary Lymphoid Structures: Autoimmunity Goes Local.
    Pipi E; Nayar S; Gardner DH; Colafrancesco S; Smith C; Barone F
    Front Immunol; 2018; 9():1952. PubMed ID: 30258435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor tissue-specific exosome profiling enables noninvasive monitoring of acute rejection in mouse allogeneic heart transplantation.
    Habertheuer A; Korutla L; Rostami S; Reddy S; Lal P; Naji A; Vallabhajosyula P
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2479-2489. PubMed ID: 29499866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.
    Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP
    J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
    Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
    PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig.
    Koga S; Auerbach MB; Engeman TM; Novick AC; Toma H; Fairchild RL
    J Immunol; 1999 Nov; 163(9):4878-85. PubMed ID: 10528189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
    Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
    J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma.
    Braun MY; Desalle F; Le Moine A; Pretolani M; Matthys P; Kiss R; Goldman M
    Eur J Immunol; 2000 May; 30(5):1290-6. PubMed ID: 10820374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection.
    Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV
    J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.
    Zhang Z; Kaptanoglu L; Haddad W; Ivancic D; Alnadjim Z; Hurst S; Tishler D; Luster AD; Barrett TA; Fryer J
    J Immunol; 2002 Apr; 168(7):3205-12. PubMed ID: 11907073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular vesicles in allograft rejection and tolerance.
    Benichou G; Wang M; Ahrens K; Madsen JC
    Cell Immunol; 2020 Mar; 349():104063. PubMed ID: 32087929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts.
    Gocht A; Distler JHW; Spriewald B; Ramsperger-Gleixner M; Weyand M; Ensminger SM; Heim C
    Transpl Immunol; 2018 Aug; 49():43-53. PubMed ID: 29649585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts.
    Smith CR; Jaramillo A; Liu W; Tu Y; Kaleem Z; Swanson CJ; Mohanakumar T
    Transplantation; 2001 Jun; 71(11):1640-8. PubMed ID: 11435977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New insights into immune mechanisms of antiperlecan/LG3 antibody production: Importance of T cells and innate B1 cells.
    Padet L; Dieudé M; Karakeussian-Rimbaud A; Yang B; Turgeon J; Cailhier JF; Cardinal H; Hébert MJ
    Am J Transplant; 2019 Mar; 19(3):699-712. PubMed ID: 30129231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
    Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
    Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts.
    Simonson MS; Herman WH; Robinson A; Schulak J; Hricik DE
    Transplantation; 1999 Jun; 67(12):1542-7. PubMed ID: 10401760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.
    Mahesh B; Leong HS; McCormack A; Sarathchandra P; Holder A; Rose ML
    Am J Pathol; 2007 Apr; 170(4):1415-27. PubMed ID: 17392180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.